TrialBlood advances2020

Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study.

Vikas Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.